Clinical significance of serum concentration of lnterleukin-8 in patients with bronchial asthma or chronic pulmonary emphysema

Respiration

Volumn 63, Issue 4, 1996, Pages 236-240

  Kanazawa, Hiroshi ^a   Kurihara, Naotsugu ^a   Otsuka, Toshihiro ^a   Fujii, Tatsuo ^a   Tanaka, Shigehiro ^a   Kitdoh, Shinzoh ^a   Hirata, Kazuto ^a   Takeda, Tadanao ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bronchial asthma; IL 8; Pulmonary emphysema

Indexed keywords

CHEMOKINE; INTERLEUKIN 8;

ADULT; AGED; ARTICLE; ASTHMA; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LEUKOCYTE ACTIVATION; LUNG EMPHYSEMA; MALE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; SMOKING;

ADOLESCENT; ADULT; AGED; ASTHMA; CHRONIC DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PULMONARY EMPHYSEMA;

EID: 0029984747     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000196552     Document Type: Article

References (22)

1. Schroder JM. Mrowietz U. Morita E, Christophers E: Purification and partial biochemical characterization of a human monocyte-derived neutrophil activating peptide that lacks interleukin 1 activity.,.J Immunol 1987; 139:3474-3483.
2. Schroder JM, Sticherling M, Henneicke HH, Preissner WC, Christophers E: IL-loor tumor necrosis factor stimulates release of three NAP-i/lE-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J Immunol 1990: 144:2223-2232.
3. Gregory H, Young J, Schroder JM, Mrowietz U. Christophers E: Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP). Biochem Biophys Res Commun 1988;151:883-890.
4. Stricter RM. Kasahara K. Allen R. Showell HJ. Standiford TJ, Kunkel SL: Human neutrophils exhibit disparate chemotactic factor gene expression. Biochem Biophys Res Commun 1990:173:725-730.
5. Schroder JM. Christophers E: Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. J Immunol 1989;142:244-251.
6. Stricter RM. Chcnsue SW. Basha MA, Standiford TJ. Lynch JP. Baggiolini M. Kunkel SL: Human alveolar gene expression of interleukin 8 by tumor necrosis alpha, lipopolysaccharide and interleukin I beta. Am J Respir Cell Mol Biol 1990;2:321-326.
7. Willems J, Joniau M, Cinque E. Van Damme J: Human granulocyte chemotactic peptide (IL-8) as a specific neutrophil degranulator: Comparison with other monokines. Immunology 1989; 67:540-542.
8. Nourshargh S. Perkins JA. Showell HJ, Matsushima K, Williams TJ, Collins PD: A comparative study of the neutrophil stimulatory activity in vitro and pro-inflammatory properties in vivo of 72 amino acid and 77 amino acid IL-8. J Immunol 1992;148:106-111.
9. Van Damme J. Van Bceumcn J. Opdenakker G, Billian A: A novel, NH:-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity. J Exp Med 1988;167:1364-1376.
10. Peveri P. Walz A. Dewald B. Baggiolini M: A neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988:167:1547-1559.
11. Rot A: Some aspects of NAP-1 pathophysiology: Lung damage caused by a blood-borne cytokine; in Wcstwick J (ed): Chemotactic Cytokines. New York. Plenum Press, 1991, pp 127-135.
12. Carre PC. Mortensen RL, King TE Jr, Noble PW, Sable CL, Riches DWH: Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonarv fibrosis. J Clin Invest 1991:88:1802-1810.
13. Donnelly SC, Stieter RM, Kunkel SL, Walz A. Robertson CR. Carter DC, Grant IS, Poliak AJ. Haslctt C: Interleukin-8 (IL-8) as a predictor of progression to the adult respiratory distress syndrome (ARDS) in bronchoalveolar large (BAL) samples from at risk patients groups. Lancet 1993:341:643-647.
14. Selby C, Drost E. Lannan S. Wraith PK. Mac Nee W: Neutrophil retention in the lungs of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991:143:1359.
15. Chan-Yeung M. Dy Buncio A: Leukocyte count, smoking and lung function. Am J Med 1984:76:31-37.
16. Burnett D, Chamba A. Hill SL, Stocklcy RA: Neutrophils from subjects with chronic obstructive lung disease show enhanced chemo-taxis and cellular proteolysis. Lancet 1987;vol ii: 1043.
17. Kanazawa H, Kurihara N, Hirata K, Fujimoto S, Takeda T: The role of free radicals and neutrophil elastasc in development of pulmonary emphysema. Internal Med 1992;31:857-860.
18. Chung KF: Role of inflammation in the hyperreactivity of the airways in asthma. Thorax 1986;41:657-662.
19. Metzger WJ. Zavala P. Richerson HB: Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Am Rev Respir Dis 1987;135:433-440.
20. Kanazawa H. Kurihara N, Hirata K, Takeda T: The role of free radicals in airway obstruction in asthmatic patients. Chest 1991:100:1319-1322.
21. Larsen CG. Ardeson AO. Appella E. Oppen-heim JJ. Matsushima K: The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989:243:1464-1466.
22. Collins PD. Weg VB. Faccioli LH, Watson ML. Moqbcl R. Williams TJ: Eosinophil accumulation induced by human interleukin-8 in the guinea-pig in vivo. Immunoogy 1993;79:312-318